Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.